Back to AVXL
Fortitude Family Office, LLC → AVXL
Fortitude Family Office, LLC AVXL Position History
Anavex Life Sciences Corp. • Healthcare
Quarters held
4
Latest value
$402
Q3 2026
Peak value
$774
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $730 |
| Q1 2026 | $359 |
| Q2 2026 | $774 |
| Q3 2026 | $402 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $402 | 199 | — | — |
| Q2 2026 | $774 | 299 | — | — |
| Q1 2026 | $359 | 117 | — | — |
| Q4 2025 | $730 | 205 | — | — |
Other funds holding AVXL
$45.3M
$40.8M
$39.5M
$37.2M
$34.2M
$33.9M
$29.3M
Other Fortitude Family Office, LLC positions
ETHA
$50.9MISHARES CORE S&P 500 ETF
ETHA
$46.4MISHARES CORE S&P 500 ETF
VGES
$37.3MVANGUARD 0-3 MONTH TREASURY BILL ETF
ETHA
$36.4MISHARES CORE S&P 500 ETF
ETHA
$34.7MISHARES CORE S&P 500 ETF
ETHA
$33MISHARES CORE S&P 500 ETF
ETHA
$30.4MISHARES CORE MSCI INTERNATIONAL DEVELOPED MARKETS ETF
VGES
$29.8MVANGUARD 0-3 MONTH TREASURY BILL ETF